264 related articles for article (PubMed ID: 15994736)
1. Methodological concerns in a trial of ziprasidone and olanzapine.
Carnahan RM; Perry PJ
Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994736
[No Abstract] [Full Text] [Related]
2. Methodological concerns in a trial of ziprasidone and olanzapine.
Ross DE
Am J Psychiatry; 2005 Jul; 162(7):1391; author reply 1391-2. PubMed ID: 15994735
[No Abstract] [Full Text] [Related]
3. Randomized, controlled, double-blind multicenter comparison of the efficacy and tolerability of ziprasidone and olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder.
Simpson GM; Glick ID; Weiden PJ; Romano SJ; Siu CO
Am J Psychiatry; 2004 Oct; 161(10):1837-47. PubMed ID: 15465981
[TBL] [Abstract][Full Text] [Related]
4. Real-life switching strategies with second-generation antipsychotics.
Correll CU
J Clin Psychiatry; 2006 Jan; 67(1):160-1. PubMed ID: 16426102
[No Abstract] [Full Text] [Related]
5. Methodological issues in a comparative study of ziprasidone and risperidone.
Gharabawi GM; Bossie CA; Mahmoud R; Canuso CM; Lasser RA; Turkoz I; Greenspan A
J Clin Psychiatry; 2006 Jan; 67(1):162-3; author reply 163-4. PubMed ID: 16426103
[No Abstract] [Full Text] [Related]
6. Clinical experiences and clinical trials.
Fusar-Poli RR
CNS Spectr; 2008 Jun; 13(6):461-2; author reply 462-3. PubMed ID: 18567969
[No Abstract] [Full Text] [Related]
7. Ziprasidone and mania.
Ross DE
Am J Psychiatry; 2004 Aug; 161(8):1503. PubMed ID: 15285991
[No Abstract] [Full Text] [Related]
8. Comments on the report of neuroleptic malignant syndrome induced by ziprasidone.
Margetic B; Aukst-Margetic B
World J Biol Psychiatry; 2007; 8(2):131-2; author reply 133-4. PubMed ID: 17455107
[No Abstract] [Full Text] [Related]
9. Strategies for successful clinical management of schizophrenia with ziprasidone.
Fagiolini A; Cañas F; Gallhofer B; Larmo I; Levy P; Montes JM; Papageorgiou G; Zink M; Rossi A
Expert Opin Pharmacother; 2010 Sep; 11(13):2199-220. PubMed ID: 20658947
[TBL] [Abstract][Full Text] [Related]
10. Olanzapine versus ziprasidone: results of a 28-week double-blind study in patients with schizophrenia.
Breier A; Berg PH; Thakore JH; Naber D; Gattaz WF; Cavazzoni P; Walker DJ; Roychowdhury SM; Kane JM
Am J Psychiatry; 2005 Oct; 162(10):1879-87. PubMed ID: 16199834
[TBL] [Abstract][Full Text] [Related]
11. Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.
Ou JJ; Xu Y; Chen HH; Fan X; Gao K; Wang J; Guo XF; Wu RR; Zhao JP
Psychopharmacology (Berl); 2013 Feb; 225(3):627-35. PubMed ID: 22926006
[TBL] [Abstract][Full Text] [Related]
12. Six-month, blinded, multicenter continuation study of ziprasidone versus olanzapine in schizophrenia.
Simpson GM; Weiden P; Pigott T; Murray S; Siu CO; Romano SJ
Am J Psychiatry; 2005 Aug; 162(8):1535-8. PubMed ID: 16055779
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of early changes in triglycerides and weight for longer-term changes in metabolic measures during olanzapine, ziprasidone or aripiprazole treatment for schizophrenia and schizoaffective disorder post hoc analyses of 3 randomized, controlled clinical trials.
Hoffmann VP; Case M; Stauffer VL; Jacobson JG; Conley RR
J Clin Psychopharmacol; 2010 Dec; 30(6):656-60. PubMed ID: 21105275
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and tolerability of ziprasidone vs. olanzapine in naive first-episode schizophrenia: a 6-week, randomized, open-label, flexible-dose study.
Li YM; Zhao JP; Ou JJ; Wu RR
Pharmacopsychiatry; 2012 Jul; 45(5):177-81. PubMed ID: 22290206
[TBL] [Abstract][Full Text] [Related]
15. [Switching patients with schizophrenia to ziprasidone from conventional or other atypical antipsychotics].
Bartkó G; Trixler M; Bitter I; Degrell I; Füredi J; Faludi G;
Neuropsychopharmacol Hung; 2006 Dec; 8(4):201-9. PubMed ID: 17211055
[TBL] [Abstract][Full Text] [Related]
16. Ziprasidone augmentation of clozapine in 11 patients.
Kaye NS
J Clin Psychiatry; 2003 Feb; 64(2):215-6. PubMed ID: 12633133
[No Abstract] [Full Text] [Related]
17. Ziprasidone hydrochloride.
Am J Health Syst Pharm; 2002 Jan; 59(1):28-9. PubMed ID: 11813463
[No Abstract] [Full Text] [Related]
18. Switching among antipsychotics in everyday clinical practice: focus on ziprasidone.
Rossi A; Cañas F; Fagiolini A; Larmo I; Levy P; Montes JM; Papageorgiou G; Sturlason R; Zink M; Correll CU
Postgrad Med; 2011 Jan; 123(1):135-59. PubMed ID: 21293094
[TBL] [Abstract][Full Text] [Related]
19. Worsened agitation and confusion in schizophrenia subsequent to high-dose aripiprazole.
Thone J
J Neuropsychiatry Clin Neurosci; 2007; 19(4):481-2. PubMed ID: 18070865
[No Abstract] [Full Text] [Related]
20. Aripirazole-olanzapine combination for treatment of schizophrenia.
Duggal HS
Can J Psychiatry; 2004 Feb; 49(2):151. PubMed ID: 15065751
[No Abstract] [Full Text] [Related]
[Next] [New Search]